Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22044339

Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

Author
MOK, Tony S. K; WU, Yi-Long; CHUA-TAN, Marina; SRIURANPONG, Virote; SUDOYO, Aru W; JIN, Kate; JOHNSTON, Michael; CHUI, Winsome; LEE, Jin-Soo; YU, Chong-Jen; CAICUN ZHOU; CHEN, Yuh-Min; LI ZHANG; IGNACIO, Jorge; MEILIN LIAO; SRIMUNINNIMIT, Vichien; BOYER, Michael
[1] The Chinese University of Hong Kong, Sir YK Pau Cancer Center, State Key Laboratory of Southern China, Prince of Wales Hospital, China
[2] Roche Hong Kong, Hong-Kong
[3] Guangdong General Hospital; Cancer Center of Sun Yat-Sen University, Guangzhou, China
[4] Shanghai Pulmonary Hospital, China
[5] Shanghai Chest Hospital, Shanghai, China
[6] National Taiwan University Hospital, Taiwan, Province of China
[7] Taipei Veterans General Hospital, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Province of China
[8] Philippine General Hospital; Cardinal Santos Medical Center, Manila, Philippines
[9] Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand
[10] The King Chulalongkorn Memorial Hospital and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
[11] Sydney Cancer Centre, Australia
[12] Roche Products, Sydney, Australia
[13] Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
[14] National Cancer Center, Goyang, Gyeonggi, Korea, Republic of
Source

Journal of clinical oncology. 2009, Vol 27, Num 30, pp 5080-5087, 8 p ; ref : 29 ref

ISSN
0732-183X
Scientific domain
Medical oncology
Publisher
American Society of Clinical Oncology, Alexandria, VA
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Anticancéreux Cancer du poumon Cancérologie Carcinome non petite cellule bronchopulmonaire Erlotinib Essai clinique phase II Placebo Randomisation Stade avancé Séquentiel Traitement de première intention Cancer Dérivé de la quinazoline Enzyme Inhibiteur de la tyrosine kinase Inhibiteur enzyme Pathologie de l'appareil respiratoire Pathologie des bronches Pathologie des poumons Protein-tyrosine kinase Transferases Tumeur maligne
Keyword (en)
Antineoplastic agent Lung cancer Cancerology non-small cell lung carcinoma Erlotinib Phase II trial Placebo Randomization Advanced stage Sequential First line treatment Cancer Quinazoline derivatives Enzyme Tyrosine kinase inhibitor Enzyme inhibitor Respiratory disease Bronchus disease Lung disease Protein-tyrosine kinase Transferases Malignant tumor
Keyword (es)
Anticanceroso Cáncer del pulmón Cancerología Carcinoma no pequeňa célula bronchopulmonar Erlotinib Ensayo clínico fase II Placebo Aleatorización Estadio avanzado Secuencial Tratamiento de primera línea Cáncer Enzima Inhibidor tyrosine kinase Inhibidor enzima Aparato respiratorio patología Bronquio patología Pulmón patología Protein-tyrosine kinase Transferases Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11A Tumors of the respiratory system and mediastinum

Discipline
Pulmonology Tumours
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
22044339

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web